drugset / Trial / NCT00791102
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to see whether ASP-1001 when given as a nasal spray is safe and can reduce the signs and symptoms of allergic rhinitis (hayfever) following nasal challenge with antigen.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-09
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ASP-1001 | Unknown | 0.2 ml | Intranasal |